Call for Artists: Design the Next HeartWorks Wine Label

Porter Family Vineyards is bottling a new vintage of HeartWorks Wine and we’re inviting artists from the CHD community to help bring it to life.

This label is more than a design. It’s a story. A perspective. A reflection of what it means to live with congenital heart disease.

If you or your child has CHD, this is your opportunity to share that story through art.

We are incredibly grateful for our long-time partners, Porter Family Vineyards. Through their generosity – donations, wine proceeds, and continued support – they have helped move this work forward in meaningful ways. This collaboration is one more way we bring the CHD community into everything we build.


Submission Details

Deadline: May 21
Who can submit: Artists impacted by CHD (children and adults)

Artwork requirements:

  • Must be portrait orientation (vertical)
  • Artist should sign their first name on the artwork
  • Please keep the original piece (winner will mail it to the vineyard)

What Happens Next

One artist will be selected to have their artwork featured on 600+ bottles of HeartWorks Wine, shared with supporters across the country.

All artists who submit will receive a small token of appreciation from HeartWorks as a thank you for sharing their creativity and story.


Why It Matters

Every bottle helps spark conversations, raise awareness, and support the future of congenital heart disease innovation.

This is your chance to be part of that story!

Purchase last year’s bottle here: https://porterfamilyvineyards.com/HeartWorksIV

Share the Post:

Related Posts

HeartWorks lab robot automating patient-specific cell manufacturing for congenital heart disease research

HeartWorks Introduces Lab Robots to Advance Cell Manufacturing

HeartWorks uses six-axis robotic systems to automate portions of patient-specific cell manufacturing, including cell passaging. The robots are designed to perform highly precise, repeatable movements and are part of HeartWorks’ effort to explore how automation and advanced imaging can make personalized cell manufacturing more consistent, efficient, and scalable for congenital heart disease therapies.

Read More
Baby at HeartWorks Office

New to HeartWorks? Here’s Where to Start.

HeartWorks is preparing to treat congenital heart disease patients with personalized cardiac cell therapy grown from their own cells. Learn how the Your Heart Program is moving regenerative medicine from the lab into human application and how you can be part of it.

Read More

Send A Message

This field is for validation purposes and should be left unchanged.
Name(Required)
Please let us know what's on your mind. Have a question for us? Ask away.